Authors:
Eastell, R
Reid, DM
Compston, J
Cooper, C
Fogelman, I
Francis, RM
Hay, SM
Hosking, DJ
Purdie, DW
Ralston, SH
Reeve, J
Russell, RGG
Stevenson, JC
Citation: R. Eastell et al., Secondary prevention of osteoporosis: when should a non-vertebral fracturebe a trigger for action?, QJM-MON J A, 94(11), 2001, pp. 575-597
Authors:
Oleksik, A
Ott, SM
Vedi, S
Bravenboer, N
Compston, J
Lips, P
Citation: A. Oleksik et al., Bone structure in patients with low bone mineral density with or without vertebral fractures, J BONE MIN, 15(7), 2000, pp. 1368-1375
Citation: J. Compston et C. Parker, Transplantation bone disease, TREATMENT OF METABOLIC BONE DISEASE: MANAGEMENT STRATEGY AND DRUG THERAPY, 2000, pp. 111-121
Authors:
Kaufman, JM
Compston, J
Audran, MA
Avouac, B
Devogelaer, JP
Lemmel, EM
Vanhaelst, L
Reginster, JY
Citation: Jm. Kaufman et al., Recommendations for the registration of drugs intended for use in the treatment of male osteoporosis, CALCIF TIS, 65(1), 1999, pp. 4-7